Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis
Clinical trial NCT00959036 · COMPLETED
Trial details
- NCT number
- NCT00959036
- Sponsor
- Ablynx, a Sanofi company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-01-01
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.